Pharma Focus Asia

AGC Group to Establish New R&D Facility in Spain

Introduction:

AGC Inc plans to open a new R & D facility to increase synthetic pharmaceutical production base in Spain.

Features:

The new R & D facility is expected to start its operation in March 2021, while the expanded facility will come into existence in May 2022. In addition, the initiative will not only establish new R & D facility but also improve existing production facilities to achieve 1.3 times the capacity of the current production level.

This brand-new R&D center enables the development of processes from lab scale to commercial production, to deliver better and quick services to customers.

In addition, new micronisation facility is also planned to meet the rising demand for micronisation of active pharmaceutical ingredients.

AGC will continue to provide customers in each region with globally consistent, top-level quality and service in the life sciences sector.

AGC will enhance its technology and continue to pursue its goal by maximising synergies among operation sites.

Specifications:

NameAGC Group
TypeExpansion
Completion Of YearMay 2022
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?